| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Siglec-2/CD22 Fc Chimera Protein, CF |
|---|
| Description | Purity >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie? Blue Staining. MW (observed): 122-127 kDa, reducing conditions. MW (theoretical): 101.9 kDa (monomer). The Recombinant Human Siglec-2/CD22 Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human Siglec-2/CD22 Fc Chimera Protein has been validated for the following applications: Bioactivity. |
|---|
| Size | 50 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | B-cell receptor CD22, BL-CAM, B-lymphocyte cell adhesion molecule, CD22, CD22 antigenMGC130020, CD22 molecule, sialic acid binding Ig-like lectin 2, Sialic acid-binding Ig-like lectin 2, Siglec2, SIGLEC-2, SIGLEC2FLJ22814, T-cell surface antigen Leu-14 |
|---|
| Gene, Accession, CAS # | CD22, Gene ID: 933, Accession: CAA42006 |
|---|
| Catalog # | 1968-SL-050 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Siglec-2/CD22 Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 18809410, 23243285, 25187624, 29155426 |
|---|
| 產(chǎn)品資料 |
|
|